На главную
Результаты поиска “Enteral nutrition pancreatic cancer”
The Crucial Role of Nutrition in Cancer Treatment
 
01:01:18
Have you read that nutritional intervention has little impact on the progression of cancer? We present a very different perspective. Cancer cells have a unique glycolytic-dependent metabolism that creates an abnormally high demand for available carbohydrate. Reducing the carbohydrate and/or sugar availability by restricting the carbohydrate consumption and limiting the protein intake of cancer patients can improve outcomes. Creating this "bottleneck" of essential energy for cancer cells, in combination with the use of specific phytonutrients that exhibit clinical evidence of pro-autophagy, pro-apoptosis, and anti-angiogenesis, is a potentially effective adjunct therapy for many forms of cancer. Join John Bagnulo MPH, PhD for a discussion on carbohydrate restriction, nutritional ketosis, and the use of plant-based substances that exhibit clinical evidence for slowing and stopping cancer metabolism. John Bagnulo holds a Masters of Public Health and a Doctorate in Human Nutrition. He serves as Director of Nutrition Education for Functional Formularies, manufacturer of the World’s only organic, whole-food, enteral formulas for critically ill patients.
Просмотров: 1266 Functional Formularies
THE BENEFITS OF EARLY ENTERAL NUTRITION AFTER
 
01:30
9th.World Congress of the International Hepato-Pancreato-Biliary Association. 2010 Buenos Aires Argentina 2010- Pancreas-DVD 5 Free Paper 2 Pancreatic Surgery www.medicaldtv.com
Просмотров: 273 medicaldtv
Nutrition After Surgery and Long Term Management
 
01:05:27
This webinar describes short- and long-term nutritional guidelines after surgery. The presentation also covers general healthy eating tips, vitamins and supplements.
Просмотров: 2173 Pancreatic Cancer Action Network
What is a J-tube feeding? Are there various formulas? (Dena McDowell, RD)
 
01:56
Dena McDowell, RD, cancer dietitian, describes a J-tube feeding and the formulas that are used after pancreatic cancer surgery. McDowell is part of the pancreatic cancer treatment team at Froedtert & The Medical College of Wisconsin. http://www.froedtert.com/pancreatic-cancer
The Board Certified Specialist in Oncology Nutrition- CSO
 
08:18
Presented by the Oncology Nutrition Dietetic Practice Group and Commision on Dietetic Registration
Просмотров: 2872 OncologyNutritionDPG
Pancreas Condition, Have You Used The Internet To Find Information About This?
 
01:08
Sharon shares if she has used the internet to research her pancreatic condition. For more information visit http://www.EmpowHer.com
Просмотров: 187 EmpowHER
MNT Cancer Part 3
 
16:13
Table of Contents: 00:00 - Applying NCP in cancer 01:06 - Nutrition Therapy 03:12 - Nutrition Assessment and Diagnosis 05:29 - Interventions for Common Side Effectsof Cancer and Treatment 06:25 - High-Kilocalorie, High-Protein Nutritional Beverages 06:57 - Nutrition Therapy for Anorexia Treatment 10:40 - Interventions During Chemotherapy andRadiation Treatment 12:04 - Interventions Before and After Surgery 13:02 - Interventions for Hematopoietic Cell Transplantation 14:22 - Determining Nutrient Requirements 15:12 - Monitoring and Evaluation
Просмотров: 414 K Dietitian
Ablation of Neuroendocrine Cancer Liver Metastases.Teven A.
 
01:21
9th.World Congress of the International Hepato-Pancreato-Biliary Association. 2010 Buenos Aires Argentina 2010- Pancreas-DVD 16 Symposium 13 Nonfunctioning endocrine pancreatic tumorswww.medicaldtv.com
Просмотров: 765 medicaldtv
Weekly Checkup - Oncology Nutrition
 
01:31
Susan J. Speer, RD, MS, CSO, Oncology Nutrition Specialist, St. John's Regional Cancer Center, discusses oncology nutrition.
Просмотров: 55 St. John's Hospitals
The impact of preoperative malnutrition on surgery outcome in cancer patients
 
02:41
Jalid Sehouli, MD, PhD of the Charité Comprehensive Cancer Center, Berlin, Germany talks about a prospective trial looking into the nutritional status, before radical surgery (primary or relapse setting), in 174 patients with ovarian or peritoneal cancer. The study showed that poor nutritional status and low muscular mass can be a risk factor for complications during and post-surgery. Prof. Sehouli believes that using fragility scores for surgery and chemotherapy, and investing in training and nutritional supportive care can help improve the outcome of frail patients. At the Charité Comprehensive Cancer Center, before deciding on the appropriate treatment, patients receive support on how to improve their nutritional status to obtain the best possible outcome. Recorded at the 2016 Annual Meeting of the American Society of Clinical Oncology (ASCO), held in Chicago, IL.
Просмотров: 172 VJOncology
Diagnosis and staging
 
01:33
9th.World Congress of the International Hepato-Pancreato-Biliary Association. 2010 Buenos Aires Argentina 2010- Pancreas-DVD 16 Symposium 13 Nonfunctioning endocrine pancreatic tumorswww.medicaldtv.com
Просмотров: 44 medicaldtv
Premio study - Maurizio Muscaritoli on prevalence of cachexia in cancer patients
 
01:58
Prof. Maurizio Muscaritoli presents the Premio study on the prevalence of cachexia in cancer patients. Video transcript: The prevalence of cachexia and malnutrition in cancer patients may vary according to the type of tumor and the phase during which the patients are studied. We now have data coming from a national epidemiological study we ran in Italy called the Premio study (Premio means Prevalence of Malnutrition in Oncology – PreMiO) which is quite a novel concept since we studied patients at their first medical oncology visit. This was an epidemiological study carried on by the Italian society of artificial nutrition and metabolism (The Italian Society for Parenteral and Enteral Nutrition – SINPE) and the Italian association of medical oncology (Italian Association of Medical Oncology – AIOM) and gave very interesting results since we found that 62% of patients undergoing their first medical oncology visit (so not treated before) already had weight-loss... Continue here to see the full transcript, more videos and articles: http://society-scwd.org/cachexia-prevalence-muscaritoli/
Reaching the Unreachable: A Novel Over the Scope Deployment Method for Enteral Stents
 
10:14
Presented by Eric M Pauli, MD, SS25 - Video - NOTES/Flexible Endoscopy: V071
Nutrição e Câncer no Paciente Adulto
 
01:16:10
Web palestra que aborda os aspectos nutricionais do câncer no paciente adulto.
Просмотров: 538 Telessaude RN
Hospital Day 3 || Restarting my Feeding Tube Feeds!! (12/2/17)
 
13:50
Online store: https://teespring.com/stores/aubreyslymejourney-store Watch more! Introduction to me: https://www.youtube.com/watch?v=5vpXmuJKwqM&lc=z23vwbnj1sb3czopq04t1aokggiaifzdcarnzfgckmwwrk0h00410 Chronic Illness Q&A: https://www.youtube.com/watchv=7uHCfG98-3U Service dog Q&A: https://www.youtube.com/watch?v=DYF8FVdbhSk&t=35s Favorite Hospital Pants : https://www.target.com/p/women-s-pajama-pants-french-terry-gilligan-o-malley-153/-/A-52283380?lnk=rec|adaptpdph1|related_prods_vv|adaptpdph1|52283380|1 Follow us on instagram!! @aubreys.lyme.journey @bowie_the_service_dog Subscribe to my channel: I post daily vlogs to illustrate the realities of chronic illness and raise awareness 😀
Просмотров: 1559 chronicles of a chronically ill girl
Nutritional Support in Critically ill patients: Current Concepts
 
43:43
Speaker: Rifat Latifi, M.D., F.A.C.S., Professor of Surgery The University of Arizona, Tucson, Arizona latifi@surgery.arizona.edu International Virtual e-Hospital Foundation Web Designer: Flamur Bekteshi
Просмотров: 3300 Flamur Bekteshi
clinical nutrition pharmacist and TPN preparation diploma
 
01:55:33
clinical nutrition pharmacist and TPN preparation #هاام_جدآ (بالتعاون مع نقابة الصيادلة ) (#البورد_الامريكي_في_التغذية_الاكلنيكية) ● #نظرآ لسعي شركة يوني دوك في تحقيق الثقة والجودة والعمل علي الارتقاء المهني في مختلف التخصصات للصيادلة 👈● #تم توقيع عقد تعاون مشترك بين شركة يوني دوك ونقابة الصيادلة بمحافظة الفيوم في تقديم اقوي الدبلومات ● #وطبقاً للقرار الصادر من #المجلس_الأعلى_للجامعات بمساواته بتمهيدى ماجستير فى مصر #احصل الان علي اقوي دبلومة #التغذية_الاكلنيكية المؤهلة لأختبار البورد الامريكي المعتمدة من نقابة الصيادلة والخارجية المصرية #مميزات_الدبلومة : - الحصول علي فرصة كبيرة للعمل في ____________________ 1•#المستشفى ← (clinical nutrition pharmacist and TPN preparation) 2•#الجيم ← ممكن تشتغل اخصائى تغذية فى جيم من المشهورين 3•#السفر ← فرص كتير للصيادلة المتخصصين فى التغذية و(الTPN) ====== •-#التمتع بإمكانية التواصل المستمر مع اساتذة الأكاديمية بعد إنتهاء فترة الدراسة , وإمكانية عرض ومناقشة أي حالات جديدة •-#اختبارات دورية لقياس الأداء والمعلومات لدى كل دارس. • يحصل الدارس علي احدث نسخة من كتاب البورد الامريكي • يكتسب الدارس الخبرة العلمية والعملية التي تؤهله لسوق العمل من خلال اقوي المحاضرين (#Contents of Diploma) ________________ #Basics == *Macronutrients *Fiber *Fluids *ABG *Electrolytes *Pre & pro biotics *Trace elements *Vitamins #Clinical_foundation == *Enteral nutrition *Parenteral nutrition *Drug-nutrients interaction /supplements *Energy *Screening & assessment *Safety practice of parenteral nutrition #Nutrition_in_specific_diseases == *Liver diseases *Pancreatic diseases *Renal diseases *Chylothorax & chylous ascites *Solid organ transplant *Elderly *Pregnancy /milk *GIT diseases *Pulmonary failure *Diabetes *Cancer *Obesity *HIV *Wound healing *Trauma *Neurological diseases *Sepsis and infection #Regulatory_issues *Home care *Ethics *Quality *Evidence based practice *Biostatistics ___________ ●#مدة الدراسة : 20 محاضرة ( محاضرة اسبوعيآ) ======= ●#التكلفة : (4000) جنيه مصري .. بنظام الحضور (4500) جنيه مصري ...بنظام الاونلاين - (450$) لغير المصريين ●#خصم 10% لأول عشر مشتركين وخصم خاااص للمجموعات (5) دارسين او اكثر (Can be paid on 2 or 3 installments) ========== ■يمكنك الدفع في مقر الشركة و في مقر نقابة صيادلة الفيوم او عن طريق الحساب البنكي (بنك اسكندرية ) فرع قصر النيل ▪اسم الحساب : شركة يوني دوك رقم الحساب : 101796210001 (من داخل مصر ) 101796210002 (من خارج مصر) سويفت كود : ALEXAGCXXXX ======= ● #للحجز_والاستعلام : يرجي تسجيل بياناتك هنا : https://goo.gl/forms/RqT3YkO9LwuEIUR82 وسيقوم الدكتور المتخصص بالتواصل معك 👈 #للتواصل_معنا : ☎ 0222604849 📲 What's app : 01100244542 & 01012607674 & 01092458916 📞 : 01091844577 / 01100244542 / 01092458916 (فودافون كاش ) / 01012607674 📧 : register_2016@hotmail.com Website : www.unidoc-eg.org ⬅ عنوان المقر الرأيسي : 16ش . أحمد قاسم . عباس العقاد . (خلف ماكدونالدز ) مدينة نصر .. القاهرة بعض اراء الدارسين
Просмотров: 1297 UNIDOC Training
Innovating Success: Applied Medical Technology, Inc.
 
09:19
Applied Medical Technology, Inc. (AMT) is more than just a manufacturing facility; we are committed to the highest level of quality, safety, and patient care. We are interested in the whole person, not just the device they use. We are dedicated to bringing products to the market that improve the quality of patients’ and caregivers’ lives. We are able to accomplish this by bridging the gap between the medical device industry and the patient population, through various relations and partnerships. AMT works with professional clinicians, caregivers, patients and their family members to better understand the needs of the enteral nutrition community. For more information about Applied Medical Technology, Inc. please visit https://www.appliedmedical.net Subscribe for More Updates and Information http://www.youtube.com/subscription_center?add_user=AppliedMedical Follow Us! Website - https://www.appliedmedical.net/ Facebook - https://www.facebook.com/AppliedMedicalTechnology/ Twitter - https://twitter.com/AMT_Family YouTube - https://www.youtube.com/user/AppliedMedical LinkedIn - https://www.linkedin.com/company/applied-medical-technology Applied Medical Technology, Inc. (AMT) is a global leader and manufacturer of Enteral Feeding Devices and Accessories, along with a vast Surgical Line of products including disposable retractor frames, smoke and fluid evacuators and more! Our Enteral products include: MiniONE® low-profile Balloon, Non-Balloon, and Capsule Non-Balloon g-tube buttons, the G-JET® low-profile gastric-jejunal enteral tube, and the AMT Bridle™ and AMT Bridle Pro™ Nasal Tube Retaining System. We also offer for your surgical needs: Remora™ Smoke & Fluid Tube Evacuator, TLC® Self-Retaining Retractor Systems, and Wilson™ Self-Retaining Retractor Systems for Male Urologic Surgery. All AMT products are proudly made in the USA! Innovating. Educating. Changing Lives.™ Contact Us Email: USA: CS@AppliedMedical.net International: ICS@AppliedMedical.net Phone: Toll Free: 1-800-869-7382 Legal: https://www.appliedmedical.net/legal/ https://www.appliedmedical.net/patents/ https://www.appliedmedical.net/trademarks/
Просмотров: 564 AppliedMedical
Dr. Adam Slivka Clinical Case - 2-6 Removal of Plastic Pancreatic and Biliary Stents
 
05:14
Adam Slivka, MD, PhD, Associate Chief, Clinical Services Division of GI, Hepatology & Nutrition; University of Pittsburg Medical Center, demonstrates the Evolution® Duodenal Controlled-Release Stent - Uncovered INSTRUCTIONS FOR USE (IFU): https://www.cookmedical.com/data/IFU_PDF/IFU0053-9.PDF MORE INFO: https://www.cookmedical.com/product/-/catalog/evolution--duodenal-uncovered-controlledrelease-stent?ds=esc_evo_duo_webds INTENDED USE: This device is used for palliative treatment of duodenal or gastric outlet obstruction and duodenal strictures caused by malignant neoplasms. STENT DESCRIPTION: This flexible, self-expanding stent is constructed of a single, woven, nitinol wire. The stent foreshortens due to its design. The total length of the stent is indicated by radiopaque markers on the inner catheter, indicating the actual length of the stent at nominal stent diameter. This Stent is supplied sterile and is intended for single use only. DELIVERY SYSTEM DESCRIPTION: The stent is mounted on an inner catheter, which accepts a .035 inch wire guide, and is constrained by an outer catheter. An endoscopically and fluoroscopically visible yellow marker defines the proximal end of the stent when constrained in the catheter. A pistol-grip delivery handle allows stent deployment or recapture. This Delivery System is supplied sterile and is intended for single use only. NOTES: Do not use this device for any purpose other than stated intended use. If package is opened or damaged when received, do not use. Visually inspect with particular attention to kinks, bends and breaks. If an abnormality is detected that would prohibit proper working condition, do not use. Please notify Cook for return authorization. Use of this device is restricted to a trained healthcare professional. Store in a dry location, away from temperature extremes. CONTRAINDICATIONS: Those specific to GI endoscopy and any procedure to be performed in conjunction with stent placement. Additional contraindications include, but are not limited to: enteral ischemia, suspected or impending perforation, intra-abdominal abscess/ perforation, inability to pass wire guide or stent through obstructed area, patients for whom endoscopic procedures are contraindicated, coagulopathy/patients with elevated bleeding times, benign disease. POTENTIAL COMPLICATIONS: Those associated with GI endoscopy include, but are not limited to: perforation, hemorrhage, aspiration, reflux, fever, infection, allergic reaction to medication, hypotension, respiratory depression or arrest, cardiac arrhythmia or arrest. Additional complications include, but are not limited to: pancreatitis, intestinal perforation, pain, inadequate expansion, stent misplacement and/or migration, tumor ingrowth or overgrowth, stent occlusion, ulcerations, pressure necrosis, erosion of the luminal mucosa, septicemia, foreign body sensation, bowel impaction, death (other than due to normal disease progression). PRECAUTIONS: Refer to product package label for the minimum channel size required for this device. A complete diagnostic evaluation must be performed prior to use to determine proper stent size. If wire guide or stent cannot advance through obstructed area, do not attempt to place stent. Stent should be placed using fluoroscopic monitoring with endoscopy. The stent should only be placed with the Cook delivery system, which is provided with each stent. This device is intended for palliative treatment only. Alternate methods of therapy should be investigated prior to placement. After stent placement, alternative methods of treatment such as chemotherapy and radiation should not be administered as this may increase risk of stent migration due to tumor shrinkage, stent erosion, and/or mucosal bleeding. Long-term patency of this device has not been established. Periodic evaluation is advised. WARNINGS: The stent is not intended to be removed or repositioned after stent placement and is considered a permanent implant. Attempts to remove or reposition stent after placement may cause damage to surrounding tissue or mucosa. Stent cannot be retrieved after the deployment threshold has been passed. Corresponding marks on outer catheter and delivery handle indicate when threshold has been passed. The stent contains nickel, which may cause an allergic reaction in individuals with nickel sensitivity.
Просмотров: 4363 Cook Medical Endoscopy Channel
Crista's Story - The Nebraska Medical Center
 
05:42
Because she was born with a rare intestinal disorder, little Crista has struggled for almost all of her short life. After many long hospital stays, Crista's foster mother brought her to the Intestinal Rehabilitation Program (IRP) at The Nebraska Medical Center. It changed her life. The Nebraska Medical Center began IRP in 2000 to provide consultation, treatment and long-term follow up to adults and children with intestinal failure and short bowel syndrome. Today, the program is among the best known in the world and treats patients from all over the U.S. and across the globe. The IRP team has gained global recognition for its innovative and multidisciplinary approach to the care of these patients; many of them young children. From day one, our patients and their families receive care from specialists in gastroenterology, surgery, nursing, clinical nutrition, pharmacy, social work, feeding disorders and psychology, all of whom have a particular interest and long-standing experience in the management of total parenteral nutrition (TPN) and intestinal failure. For more information on IRP or to make an appointment, visit http://www.nebraskamed.com/transplant or call 1-800-401-4444 Music for this video by Kevin MacLeod "Sunshine" and "Somewhere Sunny" http://www.incomptech.com
Просмотров: 2632 Nebraska Medicine
Hope for those needing a Feeding (PEG Tube)
 
01:09
This is the introduction and message of HOPE and ENCOURAGEMENT for people who have been told they need a feeding tube. Despite being 82 and very debilitated after months in the hospital... Congestive Heart Failure ...renal impairment ... Too weak to walk or even turn himself over in bed, my dad was determined to do whatever the speech therapist told him to do so he could get rid of the feeding tube and eat again ....and he did... In just 3.5 months!!! It is his hope that this series of videos gives you Hope and some insight to the therapy needed to make it happen...from one who's been there.
Просмотров: 94 TJSwanOH
Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients
 
04:31
Dr. John M. Levenick discusses his manuscript "Rectal Indomethacin Does Not Prevent Post-ERCP Pancreatitis in Consecutive Patients." To view abstract click here http://bit.ly/1UWvoO3.
Просмотров: 294 AmerGastroAssn
Enternal Feeding And Percutaneous Endoscopic Gastrostomy - Manipal Hospitals
 
03:51
This video is an informative animated presentation that explains in detail about Percutaneous Endoscopic Gastrostomy (PEG). Your doctor may perform a Percutaneous Endoscopic Gastrostomy (PEG) to insert a feeding tube into your stomach if you are unable to take food by your mouth for an extended period of time. Your doctor may require a PEG feeding tube if you cannot eat, digest, or absorb food due to esophageal cancer, oral surgery or stroke, major surgery, trauma, burns or anorexia, inflammation of the pancreas or radiation therapy or inflammatory bowel disease affecting the small intestine. The most commonly used PEG placement procedure is the pull method. During this procedure, your doctor will insert a lighted endoscope through your mouth and thread it down your esophagus and into your stomach. A camera attached to the endoscope will produce images of the inside of the stomach which will be displayed on a video monitor. Next your doctor will insert a needle through your skin into your stomach at the location where the PEG tube is to be placed. Watch the video to know more in detail about Percutaneous Endoscopic Gastrostomy (PEG). We are invested in the health and well-being of our community and frequently post informational videos on our channel in order to create awareness. Subscribe to our channel at http://bit.ly/2bkdHn8. To know more visit our website : https://www.manipalhospitals.com/ Get Connected Here: ================== Facebook: https://www.facebook.com/ManipalHospitalsIndia Google+: https://plus.google.com/111550660990613118698 Twitter: https://twitter.com/ManipalHealth Pinterest: https://in.pinterest.com/manipalhospital Linkedin: https://www.linkedin.com/company/manipal-hospital Instagram: https://www.instagram.com/manipalhospitals/ Foursquare: https://foursquare.com/manipalhealth Alexa: http://www.alexa.com/siteinfo/manipalhospitals.com Blog: https://www.manipalhospitals.com/blog/
Просмотров: 2552 Manipal Hospitals
Perioperative Nutrition
 
15:53
Просмотров: 148 NASPGHAN
THE BRIDGE-STENT TECHNIQUE FOR SALVAGE OF PANCREATICO-JEJUNA
 
01:31
9th.World Congress of the International Hepato-Pancreato-Biliary Association. 2010 Buenos Aires Argentina 2010- Pancreas-DVD 5 Free Paper 2 Pancreatic Surgery www.medicaldtv.com
Просмотров: 112 medicaldtv
Sue Seykora, R.D., L.D.
 
01:41
Meet Sue Seykora, a clinical dietitian at Mayo Clinic Health System.
Просмотров: 117 Mayo Clinic Health System
Pitfalls of Nutrition Protocol in ICU Prof. Sherif Mowafy
 
42:27
Pitfalls of Nutrition Protocol in ICU Prof. Sherif Mowafy
Просмотров: 640 MICC
Case Study Presentation - Pre/Post Nutrition Status for LVAD patient
 
41:16
I'm a dietetic intern at the University of Texas Medical Branch in Galveston, Texas and I'm presenting a patient that I saw during my transplant rotation.
Просмотров: 410 Jasmynn Lahner, MS, RD, LD
Anika & Mackenzie's Story: Tube Feeding & Cystic Fibrosis
 
09:29
Anika and Mackenzie are sisters with cystic fibrosis. After years of stressful mealtimes and below-average gains in weight and height, the Bradley's decided to supplement their daughters' nutrition with tube feeding. In this video, the girls and their parents discuss their experience, and explain how their lives and health have been positively impacted by the extra calories and nutrition. Presented by Ann & Robert H. Lurie Children's Hospital of Chicago (formerly Children's Memorial Hospital) www.luriechildrens.org
Laparoscopic Gastrojejunostomy 1 (CA Pancreas)
 
01:27
Просмотров: 573 poschong
The role of nutrition in ERAS surgery - Enhanced Recovery after Surgery (ERAS®)
 
25:38
ERAS Society Congress Lecture Series - The role of nutrition in ERAS surgery by Jonas Nygren
Просмотров: 431 ERAS® Society
Developing a Culture of Nutrition at a Community Cancer Center
 
01:03:43
Presenter: Rhone Levin, MEd , RD, CSO, LD, St. Luke's Mountain States Tumor Institute, describes how to develop a culture of nutrition though a better understanding of nutritional interventions cancer centers can use to care for oncology patients.
Просмотров: 229 ACCCvision
What is a Gastrocolic fistula ? | Best Health Channel
 
00:47
Malignant gastrocolic fistula formation is a rare complication of gastric carcinoma. If there is no history of previous surgery, it likely that a diagnosis will be made gastrocolic fistula secondary to primary carcinoma either the stomach or 15 1993 benign has been reported in patients taking anti inflammatory drugs and traditionally managed with surgery authors present 3 cases which illustrate wide spectrum clinical presentations. Gastrocolic fistulas are not common. Surgical treatment of gastrocolic fistula due to cancer the colon european journal clinical nutrition as a secondary benign gastric ulcers medical. Annals of internal gastrocolic fistula as a complication benign gastric ulcer. Endoscopy disclosed the fistula (b, arrow) with abnormal 27. Gastrocolic and gastrojejunocolic fistulas the american journal of management gastro colic fistula after laparoscopic sleeve gastrocolic with migration feeding tube into ajr. The common cause of gastrocolic fistula is different between eastern and fistulaturner warwick. This complication is said to occur in only a small minority (0. Search for articles by this author. Gov pmc articles pmc4276180. This un usual complication of peg tube placement has been well documented in the gastroenter ologic and nutritional percutaneous endoscopic gastrostomy (peg) become a safe effective technique for enteral feeding, with more than 216,000 tubes placed 18 gastrocolic fistula secondary to colon carcinoma is rare entity. We report a cachectic 82 year old woman who presented an upper gi x ray series demonstrated fistula between the stomach and transverse colon (a). Gastrocolic fistula report of twelve cases. 15 gastrocolic fistula (gcf) is a rare complication of both benign and malignant diseases of the gastrointestinal tract [1]. Despite its rarity, it is a lesion of unusual interest and great importance to the clinician, roent sixteen cases gastrojejunocolic gastrocolic fistula are reported. This communication in the alimentary tract produces a devastating effect on patient authors present 13 patients with gastrocolic, gastrojejunocolic, or duodenocolic fistula, majority of which were complications peptic ulcer disease its gastrocolic fistula is passage between gastric epithelium and colon. The fistula can also result in the reflux of fecal material from colon into stomach. Long term survival from gastrocolic fistula secondary to a shortcut through the gut hindawi. Gastrocolic fistula secondary to. Traditionally, peptic ulcer disease was commonly implicated in the this fact has been reported previously by von haberer 1 and gabridzhanian, 2 but generally authors who describe malignant gastrocolic fistulas, particularly a case of fistula is presented here as rare, late complication peg. Of the six gastro colic fistulaleakaparna govil bhasker, center for obesity and digestive surgery, ground floor, shiv verse colon via a gastrocolic fistula. We review the 10 year experience in our center of 15 cases that procedure robotic resection gastrocolic fistula and insertion gastrostomy tube, repair. Gov pmc articles pmc4276180 15 gastrocolic fistula (gcf) is a rare complication of both benign and malignant diseases the gastrointestinal tract [1]. Description of procedure malignant gastrocolic fistulathe development fistulae between two segments the gastrointestinal tract is a rare complication either. Seven cases of gastrojejunocolic fistulas followed operations for peptic ulcers. These complications include (a) pain, feculent gastrocolic fistula is a comparatively uncommon condition. It be a complication of gastric ulcer or gastroenterostomy abstract. Gastrocolic fistula is, in the majority of cases pathological communication between stomach and transverse colon, because involved with small intestine, pancreas skin have been also documented, even though are rare gastrocolic is a presentation both benign malignant diseases gastrointestinal tract. Malignant gastrocolic fistula review of the literature and report. The pathologic physiology in gastrocolic fistula has not been fully explored, and there are conflicting opinions as to the mechanism which produces abstract. Published 21 december 1935 medical definition for the term 'gastrocolic fistula' gastrocolic fistulaa fistulous passage connecting stomach and colon relatos de casosalexandre cruz henriques, tcbc sp i; Sergio pezzolo, chiconelli fistula is a rare complication of crohn? S disease (cd). Gastrocolic fistula secondary to current diagnosis and management of malignant gastrocolic fistulas fistulagastrocolic general practice notebookfrom haller till nowadays sciencedirect. This communication in the alimentary tract produces a devastating effect on patient. Gastrocolic fistula in crohn's disease gastrointestinal endoscopygastrocolic fistularobotic resection and repair of gastrocolic aapc. Malignant gastrocolic fistula is most commonly a patient affected by subject to considerable loss of fluid and electrolytes, as well malnutritio
Просмотров: 170 BEST HEALTH Answers
How to insert your NG tube! (Nasogastric feeding tube)
 
09:48
Hello :) When you first learn to insert your nasogastric feeding tube (NG tube), sometimes it is hard to remember all the steps :S So, I made this video to help other people remember what they have to do in order to insert it properly! :) ! And YES, at some point, my mom DOES fart in the background lol. :P
Просмотров: 171764 Nathalie Bonhomme
Association Between Advances in High-Resolution Cross-Section Imaging Technologies and...
 
03:54
Dr. Maria Moris discusses her manuscript "Association Between Advances in High-Resolution Cross-Section Imaging Technologies and Increase in Prevalence of Pancreatic Cysts From 2005 to 2014." To view abstract http://bit.ly/1Rs3KWC.
Просмотров: 56 AmerGastroAssn
Having my TPN Total Parenteral Nutrion PICC Line Removed (Pulled)
 
00:58
After being hospitalized 3x this summer and put on a TPN liquid diet for 9 weeks, I finally am recovered and was able to have my PICC line removed. During this entire time I was not allowed any solid foods and could only drink water, coffee or sugar free carbonated beverages in order to allow my pancreas to completely rest. Every night I'd hook up a bag of TPN to my PICC line and it would drip 2,000 calories into me over a 12 hour period. In the morning I'd remove the bag and have 12 hours off. The pump and bag fit in a carry bag about the size of an old fashioned attache case that is like a backpack and is easily carried over the shoulder like a purse of carried by the handle. Definition of Total parenteral nutrition. Total parenteral nutrition: Intravenous feeding that provides patients with all the fluid and the essential nutrients they need when they are unable to feed themselves by mouth. Abbreviated TPN.
Просмотров: 464 TeamTRUMP Radio Network
Dr. Adam Slivka Clinical Case — Complete Procedure with 12 cm Evolution Duodenal Stent Placement
 
33:06
Adam Slivka, MD, PhD, Associate Chief, Clinical Services Division of GI, Hepatology & Nutrition; University of Pittsburg Medical Center, demonstrates the Evolution® Duodenal Controlled-Release Stent - Uncovered INSTRUCTIONS FOR USE (IFU): https://www.cookmedical.com/data/IFU_PDF/IFU0053-9.PDF MORE INFO: https://www.cookmedical.com/product/-/catalog/evolution--duodenal-uncovered-controlledrelease-stent?ds=esc_evo_duo_webds INTENDED USE: This device is used for palliative treatment of duodenal or gastric outlet obstruction and duodenal strictures caused by malignant neoplasms. STENT DESCRIPTION: This flexible, self-expanding stent is constructed of a single, woven, nitinol wire. The stent foreshortens due to its design. The total length of the stent is indicated by radiopaque markers on the inner catheter, indicating the actual length of the stent at nominal stent diameter. This Stent is supplied sterile and is intended for single use only. DELIVERY SYSTEM DESCRIPTION: The stent is mounted on an inner catheter, which accepts a .035 inch wire guide, and is constrained by an outer catheter. An endoscopically and fluoroscopically visible yellow marker defines the proximal end of the stent when constrained in the catheter. A pistol-grip delivery handle allows stent deployment or recapture. This Delivery System is supplied sterile and is intended for single use only. NOTES: Do not use this device for any purpose other than stated intended use. If package is opened or damaged when received, do not use. Visually inspect with particular attention to kinks, bends and breaks. If an abnormality is detected that would prohibit proper working condition, do not use. Please notify Cook for return authorization. Use of this device is restricted to a trained healthcare professional. Store in a dry location, away from temperature extremes. CONTRAINDICATIONS: Those specific to GI endoscopy and any procedure to be performed in conjunction with stent placement. Additional contraindications include, but are not limited to: enteral ischemia, suspected or impending perforation, intra-abdominal abscess/ perforation, inability to pass wire guide or stent through obstructed area, patients for whom endoscopic procedures are contraindicated, coagulopathy/patients with elevated bleeding times, benign disease. POTENTIAL COMPLICATIONS: Those associated with GI endoscopy include, but are not limited to: perforation, hemorrhage, aspiration, reflux, fever, infection, allergic reaction to medication, hypotension, respiratory depression or arrest, cardiac arrhythmia or arrest. Additional complications include, but are not limited to: pancreatitis, intestinal perforation, pain, inadequate expansion, stent misplacement and/or migration, tumor ingrowth or overgrowth, stent occlusion, ulcerations, pressure necrosis, erosion of the luminal mucosa, septicemia, foreign body sensation, bowel impaction, death (other than due to normal disease progression). PRECAUTIONS: Refer to product package label for the minimum channel size required for this device. A complete diagnostic evaluation must be performed prior to use to determine proper stent size. If wire guide or stent cannot advance through obstructed area, do not attempt to place stent. Stent should be placed using fluoroscopic monitoring with endoscopy. The stent should only be placed with the Cook delivery system, which is provided with each stent. This device is intended for palliative treatment only. Alternate methods of therapy should be investigated prior to placement. After stent placement, alternative methods of treatment such as chemotherapy and radiation should not be administered as this may increase risk of stent migration due to tumor shrinkage, stent erosion, and/or mucosal bleeding. Long-term patency of this device has not been established. Periodic evaluation is advised. WARNINGS: The stent is not intended to be removed or repositioned after stent placement and is considered a permanent implant. Attempts to remove or reposition stent after placement may cause damage to surrounding tissue or mucosa. Stent cannot be retrieved after the deployment threshold has been passed. Corresponding marks on outer catheter and delivery handle indicate when threshold has been passed. The stent contains nickel, which may cause an allergic reaction in individuals with nickel sensitivity.
Просмотров: 6539 Cook Medical Endoscopy Channel
Preventing Cancer Through Diet
 
09:11
Hey all, this is the first video in my new YouTube series where I talk about reducing your risk of cancer through a variety of different means. Specifically, in this video, I will be focusing on changes you can make to your diet that will reduce your risk of cancer and promote a healthier lifestyle. Here are some of the sources I used if you want to read further in depth: http://www.webmd.com/diet/features/expert-qa-anti-cancer-diet-karen-collins#2 http://time.com/4086896/which-processed-red-meats-should-you-avoid-cancer-who/ http://www.webmd.com/cancer/features/seven-easy-to-find-foods-that-may-help-fight-cancer#2 https://www.cancer.gov/about-cancer/causes-prevention/risk/diet http://www.cancer.net/navigating-cancer-care/prevention-and-healthy-living/food-and-cancer-prevention https://www.pcrm.org/health/cancer-resources/diet-cancer/nutrition/how-fiber-helps-protect-against-cancer https://thetruthaboutcancer.com/cancer-causing-foods-2/ http://www.cancerdietitian.com/2011/01/whats-the-link-between-salt-sodium-and-cancer-risk.html https://www.mdanderson.org/publications/focused-on-health/october-2014/does-diet-soda-cause-cancer.html
Просмотров: 34 Whiteboard Health
Nutritional Intervention for Crohn's Disease with The Research Center
 
02:03
Nutritional Intervention for Crohn's Disease with the Research Center at the Borland-Groover Clinic. If you have Crohn's disease and have completed induction therapy with anti-TNF therapy within the past 24 weeks you may qualify for a study using a nutritional supplement (orally administered medical food). *You may be compensated for time and travel.
Просмотров: 307 Borland Groover
How I Do It Video Series: Pylorus-preserving Pancreatoduodenectomy Germany
 
08:54
The Achilles’ heel of pancreatic head resection is the pancreatic anastomosis. We prefer a two-layer end-to-side pancreato-jejunostomy in invagination technique. The prerequisite is an adequate mobilization of the pancreatic remnant to allow for an optimal position of the dorsal seromuscular row of sutures. Part of the dorsal and ventral inner row of single PDS 4-0 sutures are two to three stiches each integrating the pancreatic duct. We include the whole transsection surface into the anastomosis to guarantee drainage also of the small side ducts. The hepatojejunostomy is performed in parachute-technique with the ventral row of single 5-0 PDS sutures prepositioned on the jejunal side. After approximation the ventral row of sutures can then be completed in back-hand fashion inside-out at the hepatic duct avoiding the back wall with high precision also in small ducts. We prefer an antecolic duodeno-jejunostomy end-to-side since it may reduce delayed gastric emptying. Intraoperative insertion of a triluminal tube allows early enteral feeding. Video Contributed to the Society for Surgery of the Alimentary Tract (SSAT) International Relations Committee "How I Do It" Video Series: Pancreatic Resection by: Ernst Klar, MD, FACS Professor and Chairman Department of Surgery Univserity of Rocktosck Rockstock Germany Visit www.ssat.com to learn more about the Society for Surgery of the Alimentary Tract.
Просмотров: 3902 SSATVideos
Importance of nutrition in Perioperative care
 
04:34
Professor Robert Martindale explains the importance of nutrition in perioperative care and it's effects. It can decrease mortality rate and hospital stay. Further studies are required to optimize patients quality of life.
Просмотров: 151 Nestlé Nutrition Institute
Surgery. Max Schmidt,MD,USA)
 
01:38
9th.World Congress of the International Hepato-Pancreato-Biliary Association. 2010 Buenos Aires Argentina 2010- Pancreas-DVD 2 DEBATE -Branch -duct IPMTs. www.medicaldtv.com
Просмотров: 58 medicaldtv
MNT Liver Diseases Part 2 (24:25)
 
24:26
Table of Contents: 03:54 - Portal Hypertension/Ascites 08:58 - Encephalopathy 09:24 - Encephalopathy 12:07 - Normal Utilization of Ammonia & Formation of Urea 13:44 - Ammonia accumulation 16:50 - Hepatitis 19:29 - Hepatitis C, D, and E 21:21 - Nutrition Therapy for Viral Hepatitis 22:55 - Viral Hepatitis – Nutrition Intervention
Просмотров: 596 K Dietitian
The Feeding Tube Vlogs: General Information and About Me
 
04:35
Do you have a feeding tube? Going to get a feeding tube? Thinking about a feeding tube? Have a loved one with a feeding tube? This is the vlog series for you! Today I'll start with my own story, as well as the basic information on different types of feeding tubes. Next week we'll talk about deciding to get the tube! Closed captions to come! Learn more and share your own stories at http://spoonshares.com Twitter: http://twitter.com/spoonshares Tumblr: http://spoonshares.tumblr.com Pinterest: http://pinterest.com/spoonshares Facebook: http://facebook.com/spoonshares
Просмотров: 265 Spoon Shares
Home TPN Infusion  3
 
18:13
Paloma home health agency inservice on tpn .The client/caregiver can define total parenteral nutrition or hyper alimentation. A. It is a hypertonic solution consisting of dextrose, amino acids, lipids, and select electrolytes and minerals. It is given through a central line to provide all nutrients for the body. B. The solution is a sterile mixture that is prepared by a pharmacist. C. The client will need to be monitored by ongoing assessments and laboratory testing. II. The client/caregiver can list possible reasons for receiving total parental nutrition therapy. A. Reduced intake of calories because of 1. Inability to absorb or digest food (i.e., severe vomiting or diarrhea, obstruction, severe burns, trauma, and cancer) B. Prolonged alteration in gastrointestinal function because of 1. Disease, requiring the bowel or other organs to rest (pancreatitis, severe inflammatory bowel disease, etc.) C. Weight loss of 10% or more of usual body weight D. Reduction in values for • Prealbumin • Serum albumin • Total lymphocyte count • Total iron-binding capacity E. Intolerance to food or enteric feedings III. The client/caregiver can demonstrate how to care for TPN solution. A. Keep TPN solution in refrigerator. B. Take next bag of solution from the refrigerator 4 to 6 hours before using, and allow solution to reach room temperature before using. C. Keep supplies in a clean, dry place. D. Keep solution away from children. E. Check solution bag before use. 1. Solution should be clear and free of floating material. If lipids are added, the solution may appear milky but free of floating material. 2. Make sure that the bag has no leaks or damage. 3. Make sure that the bag is labeled with contents and expiration date. IV. The client/caregiver can demonstrate the administration of the solution. A. Clean work area. Wash hands. Assemble equipment. B. Read the label carefully to be sure that it is exactly what the physician prescribed. C. Inspect solution and warm solution to room temperature. D. Prepare solution and tubing as instructed. E. Set the pump to infuse solution at the rate ordered by physician. F. Flush the catheter as ordered when solution is finished. V. The client/caregiver can list general care measures to prevent complications. A. Prevent infection by using strict technique as instructed. B. Inspect catheter insertion site daily for signs of redness, warmth, swelling, or drainage. C. Monitor for fluid overload by checking for any swelling in arms, legs, hands, and so forth. D. Weigh at the same time every day. E. Check urine for glucose and acetone as ordered. F. Provide good oral care frequently. G. Change dressing as ordered. H. Flush catheter as ordered. I. Take temperature as ordered. J. Use your solution exactly as directed. K. Have contact numbers for physician, pharmacist, nurse, and any other health care provider available to call if problems or questions occur. L. It is important to keep all appointments with your doctor and the laboratory. VI. The client/caregiver can list signs and symptoms of complications when receiving TPN. A. Report these side effects if they are severe or do not go away: • Mouth sores • Poor night vision • Skin changes B. Call physician or health care provider if any of the following symptoms occur: • Fever or chills • Stomach pain • Difficulty breathing • Rapid weight gain or loss • Increased urination • Upset stomach or vomiting • Confusion or memory loss • Muscle weakness, twitching, or cramps • Swelling of hands, feet, or legs • Extreme thirst • Fatigue • Changes in heartbeat • Tingling in the hands or feet • Convulsion or seizures C. Call if there is a catheter occlusion or partial occlusion: lack of flow or decreased flow of solution.
Просмотров: 763 Iron Fist
PERIOPERATIVE BLOOD TRANSFUSION AND OPERATIVE TIME ARE QUALI
 
01:24
9th.World Congress of the International Hepato-Pancreato-Biliary Association. 2010 Buenos Aires Argentina 2010- Pancreas-DVD 5 Free Paper 2 Pancreatic Surgery www.medicaldtv.com
Просмотров: 102 medicaldtv
Home Tpn Infusions  5
 
04:46
Paloma home health agency and Artex allied present an inservice for home tpn infusions.The client/caregiver can define total parenteral nutrition or hyper alimentation. A. It is a hypertonic solution consisting of dextrose, amino acids, lipids, and select electrolytes and minerals. It is given through a central line to provide all nutrients for the body. B. The solution is a sterile mixture that is prepared by a pharmacist. C. The client will need to be monitored by ongoing assessments and laboratory testing. II. The client/caregiver can list possible reasons for receiving total parental nutrition therapy. A. Reduced intake of calories because of 1. Inability to absorb or digest food (i.e., severe vomiting or diarrhea, obstruction, severe burns, trauma, and cancer) B. Prolonged alteration in gastrointestinal function because of 1. Disease, requiring the bowel or other organs to rest (pancreatitis, severe inflammatory bowel disease, etc.) C. Weight loss of 10% or more of usual body weight D. Reduction in values for • Prealbumin • Serum albumin • Total lymphocyte count • Total iron-binding capacity E. Intolerance to food or enteric feedings III. The client/caregiver can demonstrate how to care for TPN solution. A. Keep TPN solution in refrigerator. B. Take next bag of solution from the refrigerator 4 to 6 hours before using, and allow solution to reach room temperature before using. C. Keep supplies in a clean, dry place. D. Keep solution away from children. E. Check solution bag before use. 1. Solution should be clear and free of floating material. If lipids are added, the solution may appear milky but free of floating material. 2. Make sure that the bag has no leaks or damage. 3. Make sure that the bag is labeled with contents and expiration date. IV. The client/caregiver can demonstrate the administration of the solution. A. Clean work area. Wash hands. Assemble equipment. B. Read the label carefully to be sure that it is exactly what the physician prescribed. C. Inspect solution and warm solution to room temperature. D. Prepare solution and tubing as instructed. E. Set the pump to infuse solution at the rate ordered by physician. F. Flush the catheter as ordered when solution is finished. V. The client/caregiver can list general care measures to prevent complications. A. Prevent infection by using strict technique as instructed. B. Inspect catheter insertion site daily for signs of redness, warmth, swelling, or drainage. C. Monitor for fluid overload by checking for any swelling in arms, legs, hands, and so forth. D. Weigh at the same time every day. E. Check urine for glucose and acetone as ordered. F. Provide good oral care frequently. G. Change dressing as ordered. H. Flush catheter as ordered. I. Take temperature as ordered. J. Use your solution exactly as directed. K. Have contact numbers for physician, pharmacist, nurse, and any other health care provider available to call if problems or questions occur. L. It is important to keep all appointments with your doctor and the laboratory. VI. The client/caregiver can list signs and symptoms of complications when receiving TPN. A. Report these side effects if they are severe or do not go away: • Mouth sores • Poor night vision • Skin changes B. Call physician or health care provider if any of the following symptoms occur: • Fever or chills • Stomach pain • Difficulty breathing • Rapid weight gain or loss • Increased urination • Upset stomach or vomiting • Confusion or memory loss • Muscle weakness, twitching, or cramps • Swelling of hands, feet, or legs • Extreme thirst • Fatigue • Changes in heartbeat • Tingling in the hands or feet • Convulsion or seizures C. Call if there is a catheter occlusion or partial occlusion: lack of flow or decreased flow of solution.
Просмотров: 812 Iron Fist
Dr. Adam Slivka Clinical Case - 1-6 Patient History
 
02:05
Adam Slivka, MD, PhD, Associate Chief, Clinical Services Division of GI, Hepatology & Nutrition; University of Pittsburg Medical Center, demonstrates the Evolution® Duodenal Controlled-Release Stent - Uncovered INSTRUCTIONS FOR USE (IFU): https://www.cookmedical.com/data/IFU_PDF/IFU0053-9.PDF MORE INFO: https://www.cookmedical.com/product/-/catalog/evolution--duodenal-uncovered-controlledrelease-stent?ds=esc_evo_duo_webds INTENDED USE: This device is used for palliative treatment of duodenal or gastric outlet obstruction and duodenal strictures caused by malignant neoplasms. STENT DESCRIPTION: This flexible, self-expanding stent is constructed of a single, woven, nitinol wire. The stent foreshortens due to its design. The total length of the stent is indicated by radiopaque markers on the inner catheter, indicating the actual length of the stent at nominal stent diameter. This Stent is supplied sterile and is intended for single use only. DELIVERY SYSTEM DESCRIPTION: The stent is mounted on an inner catheter, which accepts a .035 inch wire guide, and is constrained by an outer catheter. An endoscopically and fluoroscopically visible yellow marker defines the proximal end of the stent when constrained in the catheter. A pistol-grip delivery handle allows stent deployment or recapture. This Delivery System is supplied sterile and is intended for single use only. NOTES: Do not use this device for any purpose other than stated intended use. If package is opened or damaged when received, do not use. Visually inspect with particular attention to kinks, bends and breaks. If an abnormality is detected that would prohibit proper working condition, do not use. Please notify Cook for return authorization. Use of this device is restricted to a trained healthcare professional. Store in a dry location, away from temperature extremes. CONTRAINDICATIONS: Those specific to GI endoscopy and any procedure to be performed in conjunction with stent placement. Additional contraindications include, but are not limited to: enteral ischemia, suspected or impending perforation, intra-abdominal abscess/ perforation, inability to pass wire guide or stent through obstructed area, patients for whom endoscopic procedures are contraindicated, coagulopathy/patients with elevated bleeding times, benign disease. POTENTIAL COMPLICATIONS: Those associated with GI endoscopy include, but are not limited to: perforation, hemorrhage, aspiration, reflux, fever, infection, allergic reaction to medication, hypotension, respiratory depression or arrest, cardiac arrhythmia or arrest. Additional complications include, but are not limited to: pancreatitis, intestinal perforation, pain, inadequate expansion, stent misplacement and/or migration, tumor ingrowth or overgrowth, stent occlusion, ulcerations, pressure necrosis, erosion of the luminal mucosa, septicemia, foreign body sensation, bowel impaction, death (other than due to normal disease progression). PRECAUTIONS: Refer to product package label for the minimum channel size required for this device. A complete diagnostic evaluation must be performed prior to use to determine proper stent size. If wire guide or stent cannot advance through obstructed area, do not attempt to place stent. Stent should be placed using fluoroscopic monitoring with endoscopy. The stent should only be placed with the Cook delivery system, which is provided with each stent. This device is intended for palliative treatment only. Alternate methods of therapy should be investigated prior to placement. After stent placement, alternative methods of treatment such as chemotherapy and radiation should not be administered as this may increase risk of stent migration due to tumor shrinkage, stent erosion, and/or mucosal bleeding. Long-term patency of this device has not been established. Periodic evaluation is advised. WARNINGS: The stent is not intended to be removed or repositioned after stent placement and is considered a permanent implant. Attempts to remove or reposition stent after placement may cause damage to surrounding tissue or mucosa. Stent cannot be retrieved after the deployment threshold has been passed. Corresponding marks on outer catheter and delivery handle indicate when threshold has been passed. The stent contains nickel, which may cause an allergic reaction in individuals with nickel sensitivity.
Просмотров: 269 Cook Medical Endoscopy Channel
HOME TPN INFUSION  10
 
00:49
Paloma home health agency and Artex allied present an inservice for home tpn infusions.The client/caregiver can define total parenteral nutrition or hyper alimentation. A. It is a hypertonic solution consisting of dextrose, amino acids, lipids, and select electrolytes and minerals. It is given through a central line to provide all nutrients for the body. B. The solution is a sterile mixture that is prepared by a pharmacist. C. The client will need to be monitored by ongoing assessments and laboratory testing. II. The client/caregiver can list possible reasons for receiving total parental nutrition therapy. A. Reduced intake of calories because of 1. Inability to absorb or digest food (i.e., severe vomiting or diarrhea, obstruction, severe burns, trauma, and cancer) B. Prolonged alteration in gastrointestinal function because of 1. Disease, requiring the bowel or other organs to rest (pancreatitis, severe inflammatory bowel disease, etc.) C. Weight loss of 10% or more of usual body weight D. Reduction in values for • Prealbumin • Serum albumin • Total lymphocyte count • Total iron-binding capacity E. Intolerance to food or enteric feedings III. The client/caregiver can demonstrate how to care for TPN solution. A. Keep TPN solution in refrigerator. B. Take next bag of solution from the refrigerator 4 to 6 hours before using, and allow solution to reach room temperature before using. C. Keep supplies in a clean, dry place. D. Keep solution away from children. E. Check solution bag before use. 1. Solution should be clear and free of floating material. If lipids are added, the solution may appear milky but free of floating material. 2. Make sure that the bag has no leaks or damage. 3. Make sure that the bag is labeled with contents and expiration date. IV. The client/caregiver can demonstrate the administration of the solution. A. Clean work area. Wash hands. Assemble equipment. B. Read the label carefully to be sure that it is exactly what the physician prescribed. C. Inspect solution and warm solution to room temperature. D. Prepare solution and tubing as instructed. E. Set the pump to infuse solution at the rate ordered by physician. F. Flush the catheter as ordered when solution is finished. V. The client/caregiver can list general care measures to prevent complications. A. Prevent infection by using strict technique as instructed. B. Inspect catheter insertion site daily for signs of redness, warmth, swelling, or drainage. C. Monitor for fluid overload by checking for any swelling in arms, legs, hands, and so forth. D. Weigh at the same time every day. E. Check urine for glucose and acetone as ordered. F. Provide good oral care frequently. G. Change dressing as ordered. H. Flush catheter as ordered. I. Take temperature as ordered. J. Use your solution exactly as directed. K. Have contact numbers for physician, pharmacist, nurse, and any other health care provider available to call if problems or questions occur. L. It is important to keep all appointments with your doctor and the laboratory. VI. The client/caregiver can list signs and symptoms of complications when receiving TPN. A. Report these side effects if they are severe or do not go away: • Mouth sores • Poor night vision • Skin changes B. Call physician or health care provider if any of the following symptoms occur: • Fever or chills • Stomach pain • Difficulty breathing • Rapid weight gain or loss • Increased urination • Upset stomach or vomiting • Confusion or memory loss • Muscle weakness, twitching, or cramps • Swelling of hands, feet, or legs • Extreme thirst • Fatigue • Changes in heartbeat • Tingling in the hands or feet • Convulsion or seizures C. Call if there is a catheter occlusion or partial occlusion: lack of flow or decreased flow of solution.
Просмотров: 448 Iron Fist
TWO-STAGES STRATEGY FOR PATIENTS WITH EXTENSIVE BILATERAL CO
 
01:23
9th.World Comgress of the Intenational Hepato-Pancreato-Biliary Association-IHPBA-2010 - Buenos Aires Argentina -LIVER- DVD 6 Free Papers Colorectal Liver metastases www.medicaldtv.com
Просмотров: 76 medicaldtv